Publication
The potential of 99mTc-PEI-MP for diagnosis and 188Re-PEI-MP for therapy of bladder carcinoma
| dc.contributor.author | Ferreira, Sara | |
| dc.contributor.author | Laranjo, Mafalda | |
| dc.contributor.author | Abrantes, Ana Margarida | |
| dc.contributor.author | Brito, Ana | |
| dc.contributor.author | Metello, Luís F. | |
| dc.contributor.author | Zeevart, Jan | |
| dc.contributor.author | Louw, Werner | |
| dc.contributor.author | Dormehl, Irene | |
| dc.contributor.author | Botelho, Maria Filomena | |
| dc.date.accessioned | 2015-07-09T16:00:35Z | |
| dc.date.available | 2015-07-09T16:00:35Z | |
| dc.date.issued | 2012 | |
| dc.description.abstract | Introduction: The water-soluble polymer PEI-MP (polyethyleneimine, functionalised with methylphosphonate groups) that might be labeled with 188Re and 99mTc presents a strong potential for metabolic radiotherapy and diagnosis, respectively. The aim of this study was to evaluate in vivo the potential of 188Re-PEI-MP as therapeutic agent for bladder carcinoma and 99mTc-PEI-MP for its diagnosis and follow up | eng |
| dc.identifier.uri | http://hdl.handle.net/10400.22/6442 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.publisher | Springer | por |
| dc.title | The potential of 99mTc-PEI-MP for diagnosis and 188Re-PEI-MP for therapy of bladder carcinoma | por |
| dc.type | other | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | S443 | por |
| oaire.citation.startPage | S443 | por |
| oaire.citation.title | European Journal of Nuclear Medicine and Molecular Imaging - 25th Annual Congress of the European Association of Nuclear Medicine | por |
| oaire.citation.volume | 39 | por |
| rcaap.rights | openAccess | por |
| rcaap.type | other | por |